Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 23, 2026 08:00 ET | Source: Damora Therapeutics, Inc.

Damora Therapeutics Appoints Biotechnology Leader Jennifer Jarrett as President and Chief Executive Officer; Adds Two Industry Veterans to Board of Directors

-- Ms. Jarrett brings nearly three decades of executive leadership in biotech, tech and finance -- -- Biotech leaders Dr. Cameron Turtle and Mike Landsittel appointed to Board of Directors -- --...
March 20, 2026 08:25 ET | Source: Navigator Holdings Ltd.

Navigator Gas Announces Pricing of Upsized Secondary Public Offering by Selling Shareholder and Concurrent Repurchase of Shares by Navigator Gas

LONDON, March 20, 2026 (GLOBE NEWSWIRE) -- Navigator Holdings Ltd. (NYSE: NVGS) (“Navigator Gas,” the “Company,” “we,” or “our”) announced today the upsize and pricing of the previously announced...
March 19, 2026 16:15 ET | Source: Navigator Holdings Ltd.

Navigator Gas Announces Commencement of Secondary Public Offering by Selling Shareholder and Concurrent Repurchase of Shares by Navigator Gas

LONDON, March 19, 2026 (GLOBE NEWSWIRE) -- Navigator Holdings Ltd. (NYSE: NVGS) (“Navigator Gas,” the “Company,” “we,” or “our”) announced today that BW Group Limited, the selling shareholder of the...
March 19, 2026 16:01 ET | Source: SAB Biotherapeutics, Inc.

SAB BIO Announces Closing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants

MIAMI, March 19, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type...
March 18, 2026 16:15 ET | Source: Orchid Island Capital, Inc.

Orchid Island Capital Announces March 2026 Monthly Dividend and February 28, 2026 RMBS Portfolio Characteristics

March 2026 Monthly Dividend of $0.12 Per Share of Common StockRMBS Portfolio Characteristics as of February 28, 2026Next Dividend Announcement Expected April 15, 2026 VERO BEACH, Fla., March 18,...
March 18, 2026 09:00 ET | Source: Financial 15 Split Corp.

FINANCIAL 15 SPLIT CORP. Monthly Dividend Declaration for Class A & Preferred Share

TORONTO, March 18, 2026 (GLOBE NEWSWIRE) -- Financial 15 Split Corp. ("Financial 15") declares its regular monthly distribution of $0.12570 for each Class A share ($1.51 annualized) and $0.06042 for...
March 18, 2026 09:00 ET | Source: US Financial 15 Split Corp.

US FINANCIAL 15 SPLIT CORP. Preferred Dividend Declared

TORONTO, March 18, 2026 (GLOBE NEWSWIRE) -- US Financial 15 Split Corp ("US Financial 15") declares its monthly distribution of $0.06942 for each Preferred share, or 10.00% annually based on...
March 18, 2026 09:00 ET | Source: North American Financial 15 Split Corp

North American Financial 15 Split Corp. Monthly Dividend Declaration for Class A & Preferred Share

TORONTO, March 18, 2026 (GLOBE NEWSWIRE) -- North American Financial 15 Split Corp. (The "Company") declares its regular monthly distribution of $0.11335 for each Class A share ($1.3602 annualized)...
March 17, 2026 22:46 ET | Source: SAB Biotherapeutics, Inc.

SAB BIO Announces Pricing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants

MIAMI, March 17, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type...
March 17, 2026 16:01 ET | Source: SAB Biotherapeutics, Inc.

SAB BIO Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

MIAMI, March 17, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type...